Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 9/2018

01-09-2018 | Obesity (J McCaffery, Section Editor)

Gender and Sex Differences in Adipose Tissue

Authors: Eric Chang, Mita Varghese, Kanakadurga Singer

Published in: Current Diabetes Reports | Issue 9/2018

Login to get access

Abstract

Purpose of Review

As the ongoing epidemic of adult and childhood obesity grows, it puts a greater burden on individuals and the healthcare system due to increased prevalence of obesity-associated diseases. An important area that has gained much attention recently is the sex and gender difference related to obesity and associated complications. Basic science and clinical studies have now improved our understanding of obesity and have discovered adipose tissue biology to be key in metabolism.

Recent Findings

There is evidence related to the sex dichotomy in obesity in a variety of areas including adipocyte function, sex hormone effects, genetics, and metabolic inflammation leading to critical differences in adipose tissue biology.

Summary

The sex and gender difference in adipose tissue is a factor that should be considered when studying an individuals’ risk for obesity and metabolic dysfunction. This understanding is important for strategizing treatment and prevention measures.
Literature
1.
2.
• Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1–4. An excellent overview of how the inflammatory response to obesity can eventually lead to organ dysfunction, and how targeted therapy aimed inflammation reduction needs to be explored PubMedPubMedCentralCrossRef
3.
•• Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015;402:113–9. This article discusses the importance of sexual dimorphisms and the new and novel ways sex hormones can influence body adiposity and metabolic syndrome PubMedCrossRef
4.
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132(6):2087–102.PubMedCrossRef
5.
Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin N Am. 2016;45(4):571–9.CrossRef
6.
Varghese M, Griffin C, Singer K. The role of sex and sex hormones in regulating obesity-induced inflammation. Adv Exp Med Biol. 2017;1043:65–86.PubMedCrossRef
7.
• Kautzky-Willer A, Harreiter J, Sex PG. Gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316. Presents data on the sex-dimorphic pathophysiological mechanisms of type 2 diabetes mellitus, which is a comorbidity of obesity that continues to increase in prevalence PubMedPubMedCentralCrossRef
8.
Michaud A, Drolet R, Noël S, Paris G, Tchernof A. Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism. 2012;61(5):689–98.PubMedCrossRef
9.
Fried SK, Lee MJ, Karastergiou K. Shaping fat distribution: new insights into the molecular determinants of depot- and sex-dependent adipose biology. Obesity (Silver Spring). 2015;23(7):1345–52.CrossRef
10.
Schwartz RS, Shuman WP, Larson V, Cain KC, Fellingham GW, Beard JC, et al. The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism. 1991;40(5):545–51.PubMedCrossRef
11.
Link JC, Hasin-Brumshtein Y, Cantor RM, Chen X, Arnold AP, Lusis AJ, et al. Diet, gonadal sex, and sex chromosome complement influence white adipose tissue miRNA expression. BMC Genomics. 2017;18(1):89.PubMedPubMedCentralCrossRef
12.
13.
J. Stevens EGK, R.R. Huxley. Associations between gender, age and waist circumference. Eur J Clin Nutr 2010;64:6–15.
14.
Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001;50(4):425–35.PubMedCrossRef
15.
Snijder MB DJ, Visser M, Yudkin JS, Stehouwer CD, Bouter LM, Heine RJ, Nijpels G, Seidell JC. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res 2003;11(1):104–111.
16.
Frias JP, Macaraeg GB, Ofrecio J, Yu JG, Olefsky JM, Kruszynska YT. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes. 2001;50(6):1344–50.PubMedCrossRef
17.
Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(23):2237–8.PubMed
18.
Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med. 1995;27(4):435–8.PubMedCrossRef
19.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–808.PubMedPubMedCentralCrossRef
20.
Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11–8.PubMedCrossRef
21.
Crandall DL, Busler DE, Novak TJ, Weber RV, Kral JG. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochem Biophys Res Commun. 1998;248(3):523–6.PubMedCrossRef
22.
Lu SF, McKenna SE, Cologer-Clifford A, Nau EA, Simon NG. Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology. 1998;139(4):1594–601.PubMedCrossRef
23.
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206.PubMedPubMedCentralCrossRef
24.
Macotela Y, Boucher J, Tran TT, Kahn CR. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes. 2009;58(4):803–12.PubMedPubMedCentralCrossRef
25.
Jeffery E, Wing A, Holtrup B, Sebo Z, Kaplan JL, Saavedra-Pena R, et al. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab. 2016;24(1):142–50.PubMedPubMedCentralCrossRef
26.
Bloor ID, Symonds ME. Sexual dimorphism in white and brown adipose tissue with obesity and inflammation. Horm Behav. 2014;66(1):95–103.PubMedCrossRef
27.
Wu Y, Lee MJ, Ido Y, Fried SK. High-fat diet-induced obesity regulates MMP3 to modulate depot- and sex-dependent adipose expansion in C57BL/6J mice. Am J Physiol Endocrinol Metab. 2017;312(1):E58–71.PubMedCrossRef
28.
Ornoy A, Giron S, Aner R, Goldstein M, Boyan BD, Schwartz Z. Gender dependent effects of testosterone and 17 beta-estradiol on bone growth and modelling in young mice. Bone Miner. 1994;24(1):43–58.PubMedCrossRef
29.
Davis KE, D Neinast M, Sun K, M Skiles W, D Bills J, A Zehr J, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab 2013;2(3):227–242.
30.
Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A. 2000;97(23):12729–34.PubMedPubMedCentralCrossRef
31.
Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly YM, Rudling M, et al. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun. 2000;278(3):640–5.PubMedCrossRef
32.
Wang Y, Shoemaker R, Thatcher SE, Batifoulier-Yiannikouris F, English VL, Cassis LA. Administration of 17β-estradiol to ovariectomized obese female mice reverses obesity-hypertension through an ACE2-dependent mechanism. Am J Physiol Endocrinol Metab. 2015;308(12):E1066–75.PubMedPubMedCentralCrossRef
33.
Simpson ER, Jones ME. Of mice and men: the many guises of estrogens. Ernst Schering Found Symp Proc. 2006;1:45–67.
34.
Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000;97(23):12735–40.PubMedPubMedCentralCrossRef
35.
Nikolaenko L, Jia Y, Wang C, Diaz-Arjonilla M, Yee JK, French SW, et al. Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats. Endocrinology. 2014;155(2):417–28.PubMedCrossRef
36.
Inoue T, Zakikhani M, David S, Algire C, Blouin MJ, Pollak M. Effects of castration on insulin levels and glucose tolerance in the mouse differ from those in man. Prostate. 2010;70(15):1628–35.PubMedCrossRef
37.
Xia F, Xu X, Zhai H, Meng Y, Zhang H, Du S, et al. Castration-induced testosterone deficiency increases fasting glucose associated with hepatic and extra-hepatic insulin resistance in adult male rats. Reprod Biol Endocrinol. 2013;11:106.PubMedPubMedCentralCrossRef
38.
Floryk D, Kurosaka S, Tanimoto R, Yang G, Goltsov A, Park S, et al. Castration-induced changes in mouse epididymal white adipose tissue. Mol Cell Endocrinol. 2011;345(1–2):58–67.PubMedCrossRef
39.
• Dubois V, Laurent MR, Jardi F, Antonio L, Lemaire K, Goyvaerts L, et al. Androgen deficiency exacerbates high-fat diet-induced metabolic alterations in male mice. Endocrinology. 2016;157(2):648–65. Animal study that provides evidence that androgen deficiency in males can potentiate HFD-induced metabolic alterations. This highlights the negative implication of endogenous hypogonadism in men PubMedCrossRef
40.
Rubinow KB, Wang S, den Hartigh LJ, Subramanian S, Morton GJ, Buaas FW, et al. Hematopoietic androgen receptor deficiency promotes visceral fat deposition in male mice without impairing glucose homeostasis. Andrology. 2015;3(4):787–96.PubMedPubMedCentralCrossRef
41.
Fan W, Yanase T, Nomura M, Okabe T, Goto K, Sato T, et al. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes. 2005;54(4):1000–8.PubMedCrossRef
42.
Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5(4):197–216.PubMedCrossRef
43.
Burgoyne PS, Thornhill AR, Boudrean SK, Darling SM, Bishop CE, Evans EP. The genetic basis of XX-XY differences present before gonadal sex differentiation in the mouse. Philos Trans R Soc Lond Ser B Biol Sci 1995;350(1333):253–60 discussion 260–1.
44.
Arnold AP. Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J Neuroendocrinol. 2009;21(4):377–86.PubMedPubMedCentralCrossRef
45.
Arnold AP, Chen X. What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol. 2009;30(1):1–9.PubMedCrossRef
46.
Arnold AP. The end of gonad-centric sex determination in mammals. Trends Genet. 2012;28(2):55–61.PubMedCrossRef
47.
Chen X, McClusky R, Chen J, Beaven SW, Tontonoz P, Arnold AP, et al. The number of x chromosomes causes sex differences in adiposity in mice. PLoS Genet. 2012;8(5):e1002709.PubMedPubMedCentralCrossRef
48.
Goodfellow PN, Lovell-Badge R. SRY and sex determination in mammals. Annu Rev Genet. 1993;27:71–92.PubMedCrossRef
49.
Grove KL, Fried SK, Greenberg AS, Xiao XQ, Clegg DJ. A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int J Obes. 2010;34(6):989–1000.CrossRef
50.
Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, et al. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006;16(8):995–1004.PubMedPubMedCentralCrossRef
51.
Brune JE, Kern M, Kunath A, Flehmig G, Schön MR, Lohmann T, et al. Fat depot-specific expression of HOXC9 and HOXC10 may contribute to adverse fat distribution and related metabolic traits. Obesity (Silver Spring). 2016;24(1):51–9.CrossRef
52.
53.
54.
55.
Lopes AM, Burgoyne PS, Ojarikre A, Bauer J, Sargent CA, Amorim A, et al. Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome. BMC Genomics. 2010;11:82.PubMedPubMedCentralCrossRef
56.
57.
58.
Dai R, Ahmed SA. Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases. Ther Clin Risk Manag. 2014;10:151–63.PubMedPubMedCentral
59.
Morgan CP, Bale TL. Sex differences in microRNA regulation of gene expression: no smoke. just miRs Biol Sex Differ. 2012;3(1):22.PubMedCrossRef
60.
Pinheiro I, Dejager L, Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. BioEssays. 2011;33(11):791–802.PubMedCrossRef
61.
Victoria B, Nunez Lopez YO, Masternak MM. MicroRNAs and the metabolic hallmarks of aging. Mol Cell Endocrinol. 2017;455:131–47.PubMedCrossRef
62.
Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes. 2009;58(5):1050–7.PubMedPubMedCentralCrossRef
63.
Trajkovski M, Ahmed K, Esau CC, Stoffel M. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat Cell Biol. 2012;14(12):1330–5.PubMedCrossRef
64.
• Greenhill C. Non-coding RNA: Exosomal microRNAs as novel adipokines. Nat Rev Genet. 2017;18(4):212. Study that highlights how adipose-derived exosomal miRNAs is a class of adipokines that needs to be explored more, for it can play a role in metabolism regulation within the adipose tissue but also in distant tissues PubMedCrossRef
65.
Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450–5.PubMedPubMedCentralCrossRef
66.
Ying W, Riopel M, Bandyopadhyay G, Dong Y, Birmingham A, Seo JB, et al. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell 2017;171(2):372–384.e12.
67.
Pettersson US, Waldén TB, Carlsson PO, Jansson L, Phillipson M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One. 2012;7(9):e46057.PubMedPubMedCentralCrossRef
68.
Nickelson KJ, Stromsdorfer KL, Pickering RT, Liu TW, Ortinau LC, Keating AF, et al. A comparison of inflammatory and oxidative stress markers in adipose tissue from weight-matched obese male and female mice. Exp Diabetes Res. 2012;859395:2012.
69.
Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2(4):367–73.PubMedCrossRef
70.
Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol. 2009;29(16):4467–83.PubMedPubMedCentralCrossRef
71.
Ban JJ, Ruthenborg RJ, Cho KW, Kim JW. Regulation of obesity and insulin resistance by hypoxia-inducible factors. Hypoxia (Auckl). 2014;2:171–83.
72.
Kim M, Neinast MD, Frank AP, Sun K, Park J, Zehr JA, et al. ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue. Mol Metab. 2014;3(6):642–51.PubMedPubMedCentralCrossRef
73.
Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006;1089:538–47.PubMedCrossRef
74.
Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res. 1998;47(7):290–301.PubMedCrossRef
75.
Cuchacovich M, Gatica H, Tchernitchin AN. Role of sex hormones in autoimmune diseases. Rev Med Chil. 1993;121(9):1045–52.PubMed
76.
Singer K, Maley N, Mergian T, DelProposto J, Cho KW, Zamarron BF, et al. Differences in hematopoietic stem cells contribute to sexually dimorphic inflammatory responses to high fat diet-induced obesity. J Biol Chem. 2015;290(21):13250–62.PubMedPubMedCentralCrossRef
77.
Kim SN, Jung YS, Kwon HJ, Seong JK, Granneman JG, Lee YH. Sex differences in sympathetic innervation and browning of white adipose tissue of mice. Biol Sex Differ. 2016;7:67.PubMedPubMedCentralCrossRef
78.
González-García I, Tena-Sempere M, López M. Estradiol regulation of Brown adipose tissue thermogenesis. Adv Exp Med Biol. 2017;1043:315–35.PubMedCrossRef
79.
Taylor RW, Grant AM, Williams SM, Goulding A. Sex differences in regional body fat distribution from pre- to postpuberty. Obesity (Silver Spring). 2010;18(7):1410–6.CrossRef
80.
Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949–58.CrossRef
81.
Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509–17.PubMedPubMedCentralCrossRef
82.
Nookaew I, Svensson PA, Jacobson P, Jernås M, Taube M, Larsson I, et al. Adipose tissue resting energy expenditure and expression of genes involved in mitochondrial function are higher in women than in men. J Clin Endocrinol Metab. 2013;98(2):E370–8.PubMedCrossRef
83.
Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab. 1997;82(2):414–7.PubMedCrossRef
84.
Dieudonné MNLM, Giudicelli Y, Pecquery R. Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol. 2004;286:655–61.CrossRef
85.
Pedersen SB, JMB FH, Kristensen K, Hauner H, Richelsen B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol. 2001;182:27–37.PubMedCrossRef
86.
Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459–69.PubMedCrossRef
87.
Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51(9):2734–41.PubMedCrossRef
88.
Finkelstein JS, Yu EW, Burnett-Bowie SA. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(25):2457.PubMedCrossRef
89.
90.
91.
Dati E, Baroncelli GI, Mora S, Russo G, Baldinotti F, Parrini D, et al. Body composition and metabolic profile in women with complete androgen insensitivity syndrome. Sex Dev. 2009;3(4):188–93.PubMedCrossRef
92.
Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. 2011;96(8):2341–53.PubMedCrossRef
93.
Hamilton EJ, Gianatti E, Strauss BJ, Wentworth J, Lim-Joon D, Bolton D, et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. Clin Endocrinol. 2011;74(3):377–83.CrossRef
94.
Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab. 1998;83(6):1886–92.PubMed
95.
Francesca Amati MP, Azuma K, Dubé JJ, Toledo FGS, Rossi AP, Kelley DE, et al. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity. 2012;20(5):1115–7.PubMedCrossRef
96.
Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension. 2006;47:1019–26.PubMedCrossRef
97.
Jones THAS, Behre HM, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care. 2011;34:828–37.PubMedPubMedCentralCrossRef
98.
Kelley DEMT, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab. 2003;285:E906–E16.PubMedCrossRef
99.
Geer WS EB. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6(Suppl. 1):60–75.CrossRef
100.
Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006;55(6):1554–61.PubMedCrossRef
101.
Tchoukalova YD, Koutsari C, Votruba SB, Tchkonia T, Giorgadze N, Thomou T, et al. Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring). 2010;18(10):1875–80.CrossRef
102.
Tchoukalova YD, Koutsari C, Karpyak MV, Votruba SB, Wendland E, Jensen MD. Subcutaneous adipocyte size and body fat distribution. Am J Clin Nutr. 2008;87(1):56–63.PubMedCrossRef
103.
White UA, Tchoukalova YD. Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta. 2014;1842(3):377–92.PubMedCrossRef
104.
Shadid S, Koutsari C, Jensen MD. Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes. 2007;56(5):1369–75.PubMedCrossRef
105.
106.
• Griffin C, Lanzetta N, Eter L, Singer K. Sexually dimorphic myeloid inflammatory and metabolic responses to diet-induced obesity. Am J Physiol Regul Integr Comp Physiol. 2016;311(2):R211–6. Discusses about the sex differences in high-fat diet-induced inflammatory activation PubMedPubMedCentralCrossRef
107.
Huang ZH, Manickam B, Ryvkin V, Zhou XJ, Fantuzzi G, Mazzone T, et al. PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity. J Clin Endocrinol Metab. 2013;98(1):E17–24.PubMedCrossRef
108.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.PubMedCrossRef
109.
Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation. 2005;111(10):1242–9.PubMedCrossRef
110.
Perry AC, Martin L. Race differences in obesity and its relationship to the sex hormone milieu. Horm Mol Biol Clin Investig. 2014;19(3):151–61.PubMed
111.
• Tangpricha V, den Heijer M. Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol. 2017;5(4):291–300. This is an overview regarding transgender women on cross-sex hormone treatment and its effect pertaining to multiple areas PubMedCrossRef
112.
Moore E, Wisniewski A, Dobs A. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab. 2003;88(8):3467–73.PubMedCrossRef
113.
Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ, Spack NP, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(9):3132–54.PubMedCrossRef
114.
Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008;93(1):19–25.PubMedCrossRef
115.
Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol. 2003;58(5):562–71.CrossRef
116.
• Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: a cohort study. Maturitas. 2018;107:92–6. This study provides data on transgender individuals being treated with cross-sex hormone treatment. It focuses on the hormonal and metabolic parameters which is a useful insight on how sex hormones influence BMI, glucose homeostasis, lipids, etc PubMedCrossRef
117.
Brion MJ. Commentary: can maternal-paternal comparisons contribute to our understanding of maternal pre-pregnancy obesity and its association with offspring cognitive outcomes? Int J Epidemiol. 2013;42(2):518–9.PubMedCrossRef
118.
Butte NF, Ellis KJ, Wong WW, Hopkinson JM, Smith EO. Composition of gestational weight gain impacts maternal fat retention and infant birth weight. Am J Obstet Gynecol. 2003;189(5):1423–32.PubMedCrossRef
119.
Gale CR, Javaid MK, Robinson SM, Law CM, Godfrey KM, Cooper C. Maternal size in pregnancy and body composition in children. J Clin Endocrinol Metab. 2007;92(10):3904–11.PubMedPubMedCentralCrossRef
120.
Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol. 2004;103(3):526–33.PubMedCrossRef
121.
Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med. 2000;9(1):35–41.PubMed
122.
Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, Singh K, et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring). 2011;19(3):476–82.CrossRef
123.
Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29(3):274–81.PubMedPubMedCentralCrossRef
124.
Perrin EM, O'Shea TM, Skinner AC, Bose C, Allred EN, Fichorova RN, et al. Elevations of inflammatory proteins in neonatal blood are associated with obesity and overweight among 2-year-old children born extremely premature. Pediatr Res. 2017;
125.
Evans L, Myatt L. Sexual dimorphism in the effect of maternal obesity on antioxidant defense mechanisms in the human placenta. Placenta. 2017;51:64–9.PubMedPubMedCentralCrossRef
126.
127.
Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EH, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension. 2008;51(2):383–92.PubMedCrossRef
128.
Bayol SA, Farrington SJ, Stickland NC. A maternal ‘junk food’ diet in pregnancy and lactation promotes an exacerbated taste for ‘junk food’ and a greater propensity for obesity in rat offspring. Br J Nutr. 2007;98(4):843–51.PubMedCrossRef
129.
Pettitt DJ, Knowler WC. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care. 1998;21(Suppl 2):B138–41.PubMed
130.
McPherson NO, Fullston T, Aitken RJ, Lane M. Paternal obesity, interventions, and mechanistic pathways to impaired health in offspring. Ann Nutr Metab. 2014;64(3–4):231–8.PubMedCrossRef
131.
Patro B, Liber A, Zalewski B, Poston L, Szajewska H, Koletzko B. Maternal and paternal body mass index and offspring obesity: a systematic review. Ann Nutr Metab. 2013;63(1–2):32–41.PubMedCrossRef
Metadata
Title
Gender and Sex Differences in Adipose Tissue
Authors
Eric Chang
Mita Varghese
Kanakadurga Singer
Publication date
01-09-2018
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 9/2018
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-018-1031-3

Other articles of this Issue 9/2018

Current Diabetes Reports 9/2018 Go to the issue

Therapies and New Technologies in the Treatment of Diabetes (M Pietropaolo, Section Editor)

SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials

Obesity (J McCaffery, Section Editor)

Weight Management in Patients with Type 2 Diabetes: a Multidisciplinary Real-world Approach

Diabetes and Pregnancy (M-F Hivert and CE Powe, Section Editors)

Ethnic Disparities in Gestational Diabetes

Diabetes Epidemiology (E Selvin and K Foti, Section Editors)

Neighborhood Environments and Diabetes Risk and Control

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Simultaneous Pancreas-Kidney Transplantation Versus Living Donor Kidney Transplantation Alone: an Outcome-Driven Choice?

Other Forms of Diabetes and Its Complications (JJ Nolan and H Thabit, Section Editors)

Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits